EFFECTS OF THE MOLECULAR-WEIGHT OF HYALURONIC-ACID AND ITS ACTION MECHANISMS ON EXPERIMENTAL JOINT PAIN IN RATS

被引:119
作者
GOTOH, S
ONAYA, J
ABE, M
MIYAZAKI, K
HAMAI, A
HORIE, K
TOKUYASU, K
机构
[1] Tokyo Research Institute, Seikagaku Corporation, Higashiyamato-shi 207
关键词
D O I
10.1136/ard.52.11.817
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-It has been shown previously that hyaluronic acid (HA) has an analgesic action on bradykinin induced pain in the knee joints of rats. This study further clarifies the effects of the molecular weight of HA and its mechanism of action in the same model using HA of molecular weight 800 to 2-3 x 10(6) daltons and a bradykinin antagonist. Methods-Bradykinin and the test HA preparations were given to rats by intra-articular injection, and the severity of pain was evaluated by a change in the walking behaviour. Results-HA with a molecular weight greater than 40 kilodaltons produces analgesic effects with a simultaneous or earlier injection. The ID50 values of HA with molecular weight 40, 310, 860, and 2300 kilodaltons were greater than 2.5, 0.6, 0.07, and 0.06 mg/joint respectively. The duration of the analgesic effect of 860 and 2300 kilodalton HA was 72 hours at 10 mg/ml, whereas that of 310 kilodalton HA was short, being undetectable after 24 hours. The analgesic action of HA of 860 kilodaltons was not changed by pretreatment with four saccharide HA and inhibited by pretreatment with HA larger than six to eight saccharides, capable of binding to HA receptors. Further, HA did not interfere with the analgesic action of the bradykinin antagonist, indicating that HA does not directly bind with bradykinin receptors. Conclusions-HA with a molecular weight of greater than 40 kilodaltons produced an analgesic effect, and HA of 860 and 2300 kilodaltons produced high and long-lasting analgesia. These effects of HA appear to be caused by the interaction between HA and HA receptors.
引用
收藏
页码:817 / 822
页数:6
相关论文
共 19 条
[1]   HYALURONIC ACID IN SYNOVIAL FLUID .I. MOLECULAR PARAMETERS OF HYALURONIC ACID IN NORMAL AND ARTHRITIC HUMAN FLUIDS [J].
BALAZS, EA ;
WATSON, D ;
DUFF, IF ;
ROSEMAN, S .
ARTHRITIS AND RHEUMATISM, 1967, 10 (04) :357-&
[2]  
BRAGANTINI A, 1987, CLIN TRIALS J, V24, P333
[3]   THE CONTRIBUTION OF PAIN TO DISABILITY IN EXPERIMENTALLY INDUCED ARTHRITIS [J].
DARDICK, SJ ;
BASBAUM, AI ;
LEVINE, JD .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1017-1022
[4]   EXPERIMENTAL KNEE PAIN MODEL IN RATS AND ANALGESIC EFFECT OF SODIUM HYALURONATE (SPH) [J].
GOTOH, S ;
MIYAZAKI, K ;
ONAYA, J ;
SAKAMOTO, T ;
TOKUYASU, K ;
NAMIKI, O .
FOLIA PHARMACOLOGICA JAPONICA, 1988, 92 (01) :17-27
[5]  
Kondo H., 1980, KITASATO MED, V10, P485
[6]   LONG-TERM EFFECT OF INTRAARTICULAR INJECTIONS OF SODIUM HYALURONATE AND CORTICOSTEROID ON TEMPOROMANDIBULAR-JOINT ARTHRITIS [J].
KOPP, S ;
CARLSSON, GE ;
HARALDSON, T ;
WENNEBERG, B .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1987, 45 (11) :929-935
[7]   INHIBITION OF CARRAGEENAN INDUCED INFLAMMATION IN THE RAT KNEE-JOINT BY SUBSTANCE-P ANTAGONIST [J].
LAM, FY ;
FERRELL, WR .
ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (11) :928-932
[8]   FRACTIONATION OF HYALURONIC ACID - THE POLYDISPERSITY OF HYALURONIC ACID FROM THE BOVINE VITREOUS BODY [J].
LAURENT, TC ;
RYAN, M ;
PIETRUSZKIEWICZ, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 42 (03) :476-485
[9]   BINDING OF HYALURONATE AND CHONDROITIN SULFATE TO LIVER ENDOTHELIAL-CELLS [J].
LAURENT, TC ;
FRASER, JRE ;
PERTOFT, H ;
SMEDSROD, B .
BIOCHEMICAL JOURNAL, 1986, 234 (03) :653-658
[10]  
Laurent TC, 1970, CHEMISTRY MOLECULAR, P703, DOI DOI 10.1038/NRC3023